Clinical Trial

Antimicrobial Efficacy of Nano-Based ICM on E.F

Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated August 1, 2024 (before its estimated February 2, 2025 completion). Its status may not reflect the trial's current state.
Summary
This in-vivo study aims to evaluate the antimicrobial effect of nano based intracanal medications (Triple antibiotic-loaded chitosan nanoparticles and chlorohexidine loaded by silver nanoparticles) on Enterococcus faecalis count reduction in secondary endodontic infection cases.
Protocol Amendment History 1 change
critical Trial status changed: Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT06533215
Lead Sponsor Tanta University
Conditions Enterococcus Faecalis Infection, Endodontically Treated Teeth, Endodontic Disease
Enrollment 30 participants
Start Date 2024-01-02
Primary Completion 2025-02-02 (estimated)
Study Completion 2025-03-02 (estimated)
Updated on ClinicalTrials.gov 2024-08-01